US Food and Drug Administration approval of generic versions of complex biologics: implications for the practicing physician using low molecular weight heparins.
about
Top-down approach for the direct characterization of low molecular weight heparins using LC-FT-MS.Scientific considerations in the review and approval of generic enoxaparin in the United States.Update of the recommendations on biosimilar low-molecular-weight heparins from the Scientific Subcommittee on Control of Anticoagulation of the International Society on Thrombosis and Haemostasis.
P2860
US Food and Drug Administration approval of generic versions of complex biologics: implications for the practicing physician using low molecular weight heparins.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
US Food and Drug Administratio ...... low molecular weight heparins.
@en
US Food and Drug Administratio ...... low molecular weight heparins.
@nl
type
label
US Food and Drug Administratio ...... low molecular weight heparins.
@en
US Food and Drug Administratio ...... low molecular weight heparins.
@nl
prefLabel
US Food and Drug Administratio ...... low molecular weight heparins.
@en
US Food and Drug Administratio ...... low molecular weight heparins.
@nl
P2093
P2860
P1476
US Food and Drug Administratio ...... low molecular weight heparins.
@en
P2093
Jawed Fareed
Jose C Nicolau
Marc Cohen
Walter P Jeske
P2860
P2888
P304
P356
10.1007/S11239-012-0680-3
P577
2012-04-01T00:00:00Z